Educational resources about the HPV vaccine and HPV-related cancers. Compiled by The University of Texas MD Anderson Cancer Center Office of Health Policy.
The National HPV Vaccination Roundtable: HPV Speakers Bureau
The HPV Speakers Bureau is both a registry and a referral resource. The Bureau helps connect the public to organizations offering speakers on a variety of HPV topics. Listed organizations may include survivor groups, health professional groups, cancer centers, medical associations, and others. This service is a partnership of the HPV Roundtable with MD Anderson Cancer Center.
Project ECHO® was developed in 2003 by Dr. Sanjeev Arora of the University of New Mexico in response to a high prevalence of untreated Hepatitis C (HCV) in the state. Using this model, Dr. Arora conducted a prospective clinical trial, the results of which were published in 2011 in the New England Journal of Medicine. Dr. Arora conducted weekly videoconferences with primary care providers in 16 community clinics and 5 prisons in New Mexico. Patient cases were presented, and a multidisciplinary team at the UNM provided clinical mentoring, evidence-based advice on patient management and regular didactic education sessions. At the end of the study period, the outcomes of patients treated by specialists at UNM were compared with those of patients treated by primary care providers. The study found no significant differences in sustained viral response between the UNM cohort and the ECHO cohort. The study concluded that the ECHO model is safe and effective in treating HCV in underserved communities.
The Project ECHO model has since expanded to more than 87 hubs worldwide for nearly 30 diseases and conditions. These specialties include infectious diseases, rheumatologic diseases, chronic pain, addiction, HIV diabetes, complex multisystem disease, cancer prevention and hospice care. The VA, DOD and CDC have ongoing ECHO clinics. At MD Anderson projects are currently focused on Cervical Cancer Prevention, Management of Cervical and Breast Cancer, Tobacco Cessation for Mental Health centers, Survivorship, Palliative Care and Pathology. Visit the Project ECHO website at http://www.mdanderson.org/projectECHO to learn more.
These clinical practice algorithms have been specifically developed for MD Anderson using a multidisciplinary approach and taking into consideration circumstances particular to MD Anderson, including the following: MD Anderson’s specific patient population; our services and structure; and our clinical information. Moreover, these algorithms are not intended to replace the independent medical or professional judgment of physicians or other health care providers.
Disclaimer: These algorithms are not intended to replace the independent medical judgment of the physician or other health care providers in the context of individual clinical circumstances to determine a patient's care.
American Academy of Pediatrics HPV Champion Toolkit
The American Academy of Pediatrics has created an HPV toolkit. August is a perfect time to review materials like this and ask yourself if they may be useful in your work.
The National HPV Vaccination Roundtable believes that every health care professional plays an important role in increasing HPV vaccination rates.
Members of the Provider Training Task Group developed a suite of 6 Clinician & System Action Guides to encourage providers, support teams, and health systems to take action today.
In 2017, the Texas HPV Coalition was created by professionals and healthcare organizations concerned that Texas was falling behind in HPV vaccination rates, ranking among the worst in the nation. This assembly of doctors, nurses, researchers, nonprofit professionals and parents knew we could do better for our children.
The coalition was formed to work together to prevent HPV-related cancers and precancers by increasing HPV vaccination rates statewide. Today, the coalition represents a statewide gathering of:
Academic Researchers
Providers
Professional Organizations
State Agencies
Non-profit Agencies
Dedicated individuals
Our members include partners from diverse sectors across Texas including immunization, public health, academia, professional societies, cancer prevention and control organizations, industry, state and local agencies, and health systems.
The coalition is a catalyst to stimulate work on key issues around HPV vaccination. Through the efforts of the workgroups, the coalition will advance initiatives that focus on provider education, systems improvement, data and technology, and public awareness.
The National HPV Vaccination Roundtable is a coalition of over 70 national organizations working at the intersection of immunization and cancer prevention to raise HPV vaccination rates and prevent HPV cancers.
The Empowering Parents and Allies Task Group of the National HPV Vaccination Roundtable has launched a new Facebook group for pro-HPV vaccine families! The HPV Cancer Free FAMILY Facebook group will give families information about HPV vaccination and HPV-related cancers.
The Facebook Group – HPV Cancer Free FAMILY - will be a place where parents and family members of children 11-and 12-year-olds to:
Ask questions about HPV vaccination
Bring their worries about vaccination
Share stories about vaccination
There will be a representative of the National HPV Vaccination Roundtable on-hand to answer questions and respond to comments at least once a day Monday-Friday. Community Rules will be enforced to keep the conversation civil.
Step up to the plate and vax like a champion at the National HPV Vaccination Roundtable 2022 National Meeting. Make plans to attend on Wednesday, Sept 28, and Thursday, Sept 29. The 2-day event will feature an all-star lineup of inspiring speakers to help your team improve HPV vaccination.
Join us virtually from anywhere in the world. It’s free to attend.
The Texas HPV Coalition is hosting a four-day HPV Vaccination Summit that will take place virtually for 1.5 hours each morning [10:00-11:30 AM CST]. Each session will be led by our four workgroups with different expert speakers/panels. Sessions are open to the public. Texas HPV Coalition membership is not required. Feel free to forward to colleagues.
SESSIONS
Tuesday, December 7th - Your Words Have Weight: Promoting the HPV Vaccine
Wednesday, December 8th - The HPV Vaccine and our Community: What’s Happening?
Thursday, December 9th - Opportunities in Systems Improvement: Health Records and Interprofessional Partnerships
Friday, December 10th - 3 Ps: Data Pulls, Vaccination Patterns, and Social Media Presence
If you are interested, but cannot attend on the 18th, please contact Kelly Welch at Kelly@TeamMaureen.org
The FREE presentation is intended for DENTISTS, HYGIENISTS, DENTAL ASSISTANTS and DENTAL STUDENTS. Continuing Education Credit available. (1 hour) National expert, Dr. Alessandro Villa, DDS, PhD, MPH, will discuss:
Epidemiology of Oral HPV infections and Cancers
New FDA expanded approval for the HPV vaccine
HPV Risk factors/Symptoms
Intra-oral and extra-oral examination
The Role of the Dental Professional in HPV-related Cancer Prevention.
Dr. Villa is Chief of the Sol Silverman Oral Medicine Clinic at University of California, San Francisco, where he also serves as program director for the Oral Medicine Residency program. He served as the Program Director for the Oral Medicine Program at the Harvard School of Dental Medicine and Brigham and Women's Hospital before relocating to the West Coast, and was a founding member of the MA Oral HPV Prevention Taskforce.
This event is offered free of charge thanks to the support of Cape Cod Healthcare's Strategic Grant program.
Are you a nurse interested in empowering your clinical team to confidently initiate and complete the HPV vaccine series for your patients? The National HPV Vaccination Roundtable is hosting a train-the-trainer webinar on the HPV Prevention: Nurses Get it Done! toolkit on March 11th at 3:30pm ET. This one-hour webinar will train nurses to use the Nurses Get it Done toolkit to teach the following:
HPV 101 for Immunizers
Messages for responding to common HPV vaccine questions
Tips and resources for managing injection pain and shot aversion
The Us vs. HPV online webinar series, hosted by the American Medical Women's Association (AMWA), Global Initiative Against HPV and Cervical Cancer (GIAHC), and Indiana University, National Center of Excellence in Women's Health took place from January 27-31 2020. We had a very successful week, with the World Health Organization elaborating on the cervical cancer elimination initiative and many expert speakers discussing the 6 different types of cancers that HPV causes and the effective and excellent tools that we currently have to prevent majority of these cancers. The webinars are intended for members of the public, patients, healthcare providers, and anyone else who wishes to learn more about various aspects of HPV-related diseases and HPV prevention.
The human papillomavirus (HPV) vaccine could prevent up to 90 percent of cervical cancer cases plus a range of other cancers, including many for which there is no routine screening. Texas pediatricians play a significant role in educating patients and their parents about why it is important to be vaccinated as recommended. This podcast, by Dr. John Hellerstedt, Commissioner, Texas Department of State Health Services, provides an overview of current research and offers practical guidance about how to promote routine HPV vaccination in your practice.
Dr. Hellerstedt has served as DSHS commissioner since January 2016 and is a leading spokesman for public health issues in the state. Dr. Hellerstedt is a long-time Texas pediatrician who has been chief medical officer at the Seton Family of Hospitals and vice president of medical affairs at Dell Children’s Medical Center, both in Austin. He previously served the state as medical director for Medicaid and the Children’s Health Insurance Program.
HPV Vaccine Uptake in Texas Pediatric Care Settings: 2014-2015 Environmental Scan Report
The University of Texas MD Anderson Cancer Center in Houston has conducted a detailed assessment or "environmental scan" on HPV vaccination in pediatric care settings in Texas. The report provides an overview of HPV-related cancer burden in Texas and identifies barriers to and facilitators of HPV vaccination in the pediatric population as observed by Texas stakeholders. This project was funded by a grant from the National Cancer Institute.
MD Anderson hopes that the findings and recommendations will assist your organization in developing strategies to increase HPV vaccine uptake, enhance existing collaborations, and prevent potentially avoidable cancer diagnoses and deaths related to HPV infections.
Just like you, each clinician featured in the #HowIRecommend video series is unique in their conversational style and approach to answering parents’ questions or concerns about HPV vaccine, with a common goal to protect their patients from cancers caused by HPV. Learn how they answer common questions you get every day. The #HowIRecommend video series is organized two ways:
If there were a vaccine against cancer, would you get it for your kids? HPV is a very common virus, infecting about 14 million people annually. This educational video addresses this importance of adolescents receiving protection against HPV, a cancer-causing disease, and provides an overview of HPV vaccine recommendations. Physicians Julie Boom, MD, Lois Ramondetta, MD, Erich Sturgis, MD, and David Persse, MD, share their expertise, discuss HPV vaccine safety and talk about the importance of HPV vaccination.
Did you know the healthcare provider recommendation is the single best predictor of vaccination? What you say, and how you say it, matters. This informative video highlights physicians, Julie Boom, MD, Lois Ramondetta, MD, Erich Sturgis, MD, and David Persse, MD sharing their expertise on HPV and HPV vaccination, including how to strongly recommend the vaccine to patients/parents of your patients.
The HPV vaccine is the best protection against the HPV virus and the cancers it causes. All boys and girls between 11 and 12 should get the HPV vaccine. The vaccine is given at this age for maximum immunity. About 80% of people – both men and women – will get a human papillomavirus (HPV) infection at some point in their lives. The HPV vaccine is a safe and effective vaccination against cancer.
In July 2012, Sandy Wexler went to the dentist for a routine checkup where her dentist noticed one of Sandy’s lymph nodes was enlarged. When a biopsy revealed she had squamous cell carcinoma, she was referred to MD Anderson for treatment. While undergoing treatment at MD Anderson, Sandy discovered that her cancer was the result of the human papillomavirus (HPV). Hear Sandy's story.
Rob Joyce, 61, was diagnosed with squamous cell carcinoma on the base of his tongue. The biopsy done by his Ear, Nose and Throat physician revealed that his cancer was caused by the human papillomavirus (HPV). Listen to Rob tell his story and explain why the HPV vaccine is so important to today's youth.
Constance Hill was diagnosed with cervical cancer, caused by the human papillomavirus (HPV), in May 2014. She underwent a radical hysterectomy, radiation and chemotherapy, and brachytherapy. Then she had a recurrence and was placed on a Phase II clinical trial using the HPV vaccine and immunotherapy. Her cervical cancer is still present, so she is beginning a style="color:black;text-decoration:none;font-weight:bold;" targeted therapy Phase I clinical trial. In her mind, all of this could have been avoided if the HPV vaccine was available to her as a child. Hear Constance tell her story.
At age 62, Tom Jackson was diagnosed with prostate cancer. The diagnosis is common among men his age, so he took it in stride. But shortly before Tom was scheduled to have his prostate removed, he discovered a lump on his neck. A biopsy and CT scan of the lump revealed that Tom also had squamous cell carcinoma of the tonsil caused by the human papillomavirus (HPV).
Suzanne Armstrong was diagnosed with squamous cell carcinoma of the tonsil in December 2016. She noticed a lump on her neck, which once biopsied, turned out to be HPV-related. Listen to Suzanne tell her story and the difficulty she faced when having to undergo treatment at age 70, only six-months after her husband passed away from cancer.
Scott Courville was diagnosed with squamous cell carcinoma of the right tonsil in 2016. What two separate doctors thought was tonsillitis, turned out to be cancer caused by the human papillomavirus (HPV). Following numerous rounds of chemotherapy and radiation treatment, Scott now encourages all parents, like himself, to make sure their children get vaccinated. Hear Scott's advice for parents.
In the United States, 79 million men and women — approximately one in four — are currently infected with the human papillomavirus (HPV). From 2008 to 2012, nearly 40,000 HPV-related cancers occurred annually in the United States. Today, highly effective HPV vaccines could easily reduce these numbers, but only 42 percent of girls and 28 percent of boys aged 13 to 17 have received the vaccine — far below the 80 percent of American adolescents the Centers for Disease Control and Prevention (CDC) aim to reach. At this event, leaders from the CDC, Texas state government and The University of Texas MD Anderson Cancer Center discussed HPV, HPV-associated cancers, life-saving cancer prevention opportunities through HPV vaccination, barriers to HPV vaccination programs and a proposed plan to promote HPV vaccination in Texas.
As a cervical cancer survivor and parent to two sons, Linda Ryan advises other parents to vaccinate their kids against the human papillomavirus (HPV). She wishes the HPV vaccine had been available to her as an adolescent so she could have avoided cervical cancer, which is predominantly caused by HPV.
Cancer survivor Kara Million was diagnosed with cervical cancer, which was caused by the human papillomavirus (HPV) infection. She is now an advocate for the HPV vaccine. Watch as she shares her story and urges everyone to protect their children with the HPV vaccine.
…empowering Texans with the knowledge needed to reduce the impact of cancer. 
